ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2026
Spatiotemporal Modeling Approach to Mapping Geographic and Temporal Variation in Cancer Incidence Rates for US Counties.
Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundMapping cancer incidence is crucial for analyzing and visualizing patterns across geographic areas. Although many studies map cancer incidence at subnational levels (e.g., state, county), publicly available county-level data, especially for less common cancers, are limited.
methodsUsing data from the North American Association of Central Cancer Registries CiNA research database (2005-2019), we developed spatiotemporal hierarchical models to smooth/predict annual age group-specific case counts for all US counties. We compared Poisson and zero-truncated Poisson likelihoods and various priors. Model performance was assessed using the deviance information criterion, weighted Akaike information criterion, and average absolute relative deviation (AARD). Modeled age-adjusted rates were mapped to visualize spatial and temporal patterns.
resultsModeled age-adjusted rates were produced for 16 selected sex-specific cancer sites across 3,109 counties from 2005 to 2019. AARD values varied by site and context, being lowest for common cancers and populous counties and highest for rare cancers and sparsely populated areas. Compared with maps of observed rates, modeled maps were smoother and more coherent, filling gaps and reducing extreme values driven by small case counts while preserving large-scale geographic gradients and temporal trends.
conclusionsThe standard Poisson hierarchical mixed-effects model showed superior accuracy and computational efficiency and was selected for final estimation. As expected, the most accurate predictions are for more common cancer sites in more populous areas, and the least accurate predictions are for rarer cancers in areas with lower populations. IMPACT: The resulting estimates and maps could support surveillance, trend analysis, disparity identification, targeted interventions, and broader research efforts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.